HK1048441B - Drug for treating fractures - Google Patents

Drug for treating fractures

Info

Publication number
HK1048441B
HK1048441B HK03100502.8A HK03100502A HK1048441B HK 1048441 B HK1048441 B HK 1048441B HK 03100502 A HK03100502 A HK 03100502A HK 1048441 B HK1048441 B HK 1048441B
Authority
HK
Hong Kong
Prior art keywords
drug
treating fractures
fractures
treating
Prior art date
Application number
HK03100502.8A
Other languages
Chinese (zh)
Other versions
HK1048441A1 (en
Inventor
戴維‧G‧利特爾
Original Assignee
羅亞爾．亞歷山德拉兒童醫院
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 羅亞爾．亞歷山德拉兒童醫院 filed Critical 羅亞爾．亞歷山德拉兒童醫院
Publication of HK1048441A1 publication Critical patent/HK1048441A1/en
Publication of HK1048441B publication Critical patent/HK1048441B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK03100502.8A 1999-08-19 2003-01-21 Drug for treating fractures HK1048441B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ2325A AUPQ232599A0 (en) 1999-08-19 1999-08-19 Drug for treating fractures
PCT/AU2000/000982 WO2001013922A1 (en) 1999-08-19 2000-08-17 Drug for treating fractures

Publications (2)

Publication Number Publication Date
HK1048441A1 HK1048441A1 (en) 2003-04-04
HK1048441B true HK1048441B (en) 2008-02-22

Family

ID=3816500

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03100502.8A HK1048441B (en) 1999-08-19 2003-01-21 Drug for treating fractures

Country Status (16)

Country Link
EP (1) EP1214079A4 (en)
JP (1) JP2003507426A (en)
KR (1) KR20020027562A (en)
CN (1) CN100345548C (en)
AU (1) AUPQ232599A0 (en)
BR (1) BR0013416A (en)
CA (1) CA2381302A1 (en)
HK (1) HK1048441B (en)
HU (1) HUP0202396A3 (en)
IL (1) IL148166A0 (en)
NO (1) NO20020784D0 (en)
NZ (1) NZ517538A (en)
PL (1) PL353485A1 (en)
SK (1) SK2382002A3 (en)
WO (1) WO2001013922A1 (en)
ZA (1) ZA200202160B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1233325C (en) 2001-02-06 2005-12-28 罗亚尔·亚历山德拉儿童医院 Drug for treatment of osteonecrosis and for management of patients at risk of evelopment osteonecrosis
US20040157798A1 (en) * 2001-04-03 2004-08-12 Little David Graham Drug for use in bone grafting
AUPR553701A0 (en) * 2001-06-07 2001-07-12 Royal Alexandra Hospital For Children, The A device for the delivery of a drug to a fractured bone
ES2561463T3 (en) * 2003-08-21 2016-02-26 Addbio Ab Implant device coated with bisphosphonate and method for it
CA2539359A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bisphosphonate
ITMI20040218A1 (en) * 2004-02-10 2004-05-10 Abiogen Pharma Spa USE OF SODIUM NERHYDRONATE TO PROMOTE BONE NEOFORMATION
ITMI20040641A1 (en) * 2004-03-31 2004-06-30 Tb Technology S R L BIFUNCTIONAL BIOADHESIVE COMPOSITIONS FOR ORAL IMPLANTOLOGY
AR048742A1 (en) * 2004-12-22 2006-05-24 Gador Sa INTRA-ORAL MEDICINES APPLICATION SYSTEM
ES2379485T3 (en) * 2005-10-27 2012-04-26 Thommen Medical Ag Dental implant and manufacturing procedure
US8882740B2 (en) 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
CN114532937A (en) * 2020-11-18 2022-05-27 中国人民解放军海军军医大学第一附属医院 Enteroscope auxiliary device

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8107560A (en) * 1981-11-19 1983-07-05 Luiz Romariz Duarte ULTRASONIC STIMULATION OF BONE FRACTURE CONSOLIDATION
WO1993011786A1 (en) * 1991-12-17 1993-06-24 Procter & Gamble Pharmaceuticals, Inc. Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone
EP0600834A1 (en) * 1992-11-30 1994-06-08 Ciba-Geigy Ag Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
AU670337B2 (en) * 1992-11-30 1996-07-11 Novartis Ag Use of certain methanebisphosphonic acid derivatives in fracture healing
AU5953894A (en) * 1992-12-23 1994-07-19 Merck & Co., Inc. Bisphosphonate/estrogen therapy for treating and preventing bone loss
US5403829A (en) * 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
CA2221416A1 (en) * 1995-06-06 1996-12-12 Merck & Co., Inc. Bisphosphonate therapy for bone loss associated with rheumatoid arthritis
US5616571A (en) * 1995-06-06 1997-04-01 Merck & Co., Inc. Bisphosphonates prevent bone loss associated with immunosuppressive therapy
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
GB9613722D0 (en) * 1996-06-28 1996-08-28 Univ Liverpool Chemical compounds

Also Published As

Publication number Publication date
IL148166A0 (en) 2002-09-12
BR0013416A (en) 2002-04-30
NO20020784L (en) 2002-02-18
EP1214079A4 (en) 2004-03-24
HUP0202396A3 (en) 2005-02-28
EP1214079A1 (en) 2002-06-19
NO20020784D0 (en) 2002-02-18
CN100345548C (en) 2007-10-31
HK1048441A1 (en) 2003-04-04
CA2381302A1 (en) 2001-03-01
SK2382002A3 (en) 2002-09-10
KR20020027562A (en) 2002-04-13
WO2001013922A1 (en) 2001-03-01
JP2003507426A (en) 2003-02-25
NZ517538A (en) 2003-07-25
ZA200202160B (en) 2003-08-27
PL353485A1 (en) 2003-11-17
CN1370071A (en) 2002-09-18
AUPQ232599A0 (en) 1999-09-09
HUP0202396A2 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
HUP0200556A3 (en) Medicament for treating diabetes
HK1200316A1 (en) Therapeutic microfoams
IL138784A0 (en) Treatment for diabetes
PL350167A1 (en) Medicament for treating hypertension
GB9930570D0 (en) Therapy
GB9925136D0 (en) Novel treatment
GB9907243D0 (en) Therapy
HK1048441A1 (en) Drug for treating fractures
PL349347A1 (en) Novel treatment
GB9900222D0 (en) Therapeutic compounds
HU9902296D0 (en) Pharmaceutical composition for treating caltification
GB0020261D0 (en) Therapeutic treatment
HUP0105469A3 (en) Therapeutic drugs comprising pyrroloazepines for treating intermittent claudication
GB9924980D0 (en) Therapeutic treatment
GB9901505D0 (en) Therapeutic treatment
HU9904711D0 (en) Set for fixation fractures
GB9919721D0 (en) Medical apparatus
GB9908993D0 (en) Treatment
GB9903558D0 (en) Medical treatment
GB9923343D0 (en) Treatment system
GB9924712D0 (en) Therapeutic method
AU142194S (en) Medical treatment apparatus
GB9927106D0 (en) Cancer treatment
GB9908176D0 (en) Cancer treatment
GB9909650D0 (en) Novel treatment

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110817